AARP Hearing Center
You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.
Advocates for older Virginians urged state lawmakers and candidates recently to support a series of legislative proposals that they say would improve the lives of the state’s aging residents.
“All of these are key priorities if the goal is to make Virginia a place where everybody can age well,” said David Broder, legislative co-chair of the Northern Virginia Aging Network (NVAN) after the group’s 24th annual legislative breakfast in Fairfax. “No one is sufficient. We need all of them.”
NVAN includes the Commissions on Aging and Area Agencies on Aging of Alexandria, Arlington, Fairfax, Loudoun and Price William counties as well as regional service and advocacy organizations including AARP Virginia, which was a prime sponsor of the breakfast.
Organizers said about 180 people attended the breakfast, including numerous members of the General Assembly, staff members and candidates throughout Northern Virginia.
“It was a great showing today,” said Jared Calfee, AARP Virginia associate state director for state advocacy. “The number of elected officials and candidates that were in this room shows how serious they take aging issues in Virginia. It was really positive to see.”
The NVAN priorities outlined at the breakfast include three policy objectives and three budget goals. They include:
The NVAN legislative priorities do not include AARP Virginia’s top legislative proposal—the creation of a prescription drug affordability board with the authority to set upper payment limits on certain high-cost medicines.
Calfee said that the drug price issue is one area where NVAN and AARP are pursuing different priorities, but he was confident that the issue has the support of most Northern Virginia lawmakers and candidates.
“We have had very strong support from most everyone we’ve talked to in the legislature from Northern Virginia for that legislation,” he said. “I’m confident that the people that were in this room are by and large behind us on” the prescription drug board.